{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:34:00Z","timestamp":1792654440831,"version":"4.5.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2011,9,26]],"date-time":"2011-09-26T00:00:00Z","timestamp":1316995200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0024834","type":"journal-article","created":{"date-parts":[[2011,9,26]],"date-time":"2011-09-26T21:06:52Z","timestamp":1317071212000},"page":"e24834","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":52,"title":["Neuropathology in Mice Expressing Mouse Alpha-Synuclein"],"prefix":"10.1371","volume":"6","author":[{"given":"Claus","family":"Rieker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumlesh K.","family":"Dev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Lehnhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Ksiazek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Kauffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Danner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Schell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Boden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A.","family":"Ruegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp J.","family":"Kahle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"van der Putten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya R.","family":"Shimshek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,9,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0028-3908(02)00337-4","article-title":"Part I: parkin-associated proteins and Parkinson&apos;s disease.","volume":"45","author":"KK Dev","year":"2003","journal-title":"Neuropharmacology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","article-title":"Genetic animal models of Parkinson&apos;s disease.","volume":"66","author":"TM Dawson","year":"2010","journal-title":"Neuron"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrneurol.2010.52","article-title":"Molecular and clinical prodrome of Parkinson disease: implications for treatment.","volume":"6","author":"AH Schapira","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"49071","DOI":"10.1074\/jbc.M208046200","article-title":"Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions.","volume":"277","author":"M Hasegawa","year":"2002","journal-title":"J Biol Chem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1523\/JNEUROSCI.20-17-06365.2000","article-title":"Subcellular localization of wild-type and Parkinson&apos;s disease-associated mutant alpha -synuclein in human and transgenic mouse brain.","volume":"20","author":"PJ Kahle","year":"2000","journal-title":"J Neurosci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.20-16-06021.2000","article-title":"Neuropathology in mice expressing human alpha-synuclein.","volume":"20","author":"H van der Putten","year":"2000","journal-title":"J Neurosci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.","volume":"34","author":"BI Giasson","year":"2002","journal-title":"Neuron"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.","volume":"22","author":"D Kirik","year":"2002","journal-title":"J Neurosci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/10430340252837206","article-title":"Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra.","volume":"13","author":"RL Klein","year":"2002","journal-title":"Hum Gene Ther"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions.","volume":"4","author":"H Fujiwara","year":"2002","journal-title":"Nat Cell Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-002-0563-3","article-title":"Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred.","volume":"104","author":"JE Duda","year":"2002","journal-title":"Acta Neuropathol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1471-4159.2009.06124.x","article-title":"The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson&apos;s disease.","volume":"110","author":"FK Lee","year":"2009","journal-title":"J Neurochem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI200215777","article-title":"Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies.","volume":"110","author":"M Neumann","year":"2002","journal-title":"J Clin Invest"},{"key":"ref14","first-page":"53","article-title":"Subcellular localization of alpha-synuclein in primary neuronal cultures: effect of missense mutations.","author":"PJ McLean","year":"2000","journal-title":"J Neural Transm Suppl"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/bi961799n","article-title":"NACP, a protein implicated in Alzheimer&apos;s disease and learning, is natively unfolded.","volume":"35","author":"PH Weinreb","year":"1996","journal-title":"Biochemistry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"34393","DOI":"10.1074\/jbc.M004851200","article-title":"Interaction of human alpha-Synuclein and Parkinson&apos;s disease variants with phospholipids. Structural analysis using site-directed mutagenesis.","volume":"275","author":"RJ Perrin","year":"2000","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0028-3908(03)00140-0","article-title":"Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease.","volume":"45","author":"KK Dev","year":"2003","journal-title":"Neuropharmacology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.","volume":"287","author":"E Masliah","year":"2000","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/embo-reports\/kvf109","article-title":"Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes.","volume":"3","author":"PJ Kahle","year":"2002","journal-title":"EMBO Rep"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1570-9639(02)00435-1","article-title":"Establishment of a first-order kinetic model of light chain-associated amyloid fibril extension in vitro.","volume":"1601","author":"N Takahashi","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s004010051135","article-title":"alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining.","volume":"99","author":"E Gomez-Tortosa","year":"2000","journal-title":"Acta Neuropathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9440(10)63633-4","article-title":"Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies.","volume":"163","author":"DM Sampathu","year":"2003","journal-title":"Am J Pathol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson&apos;s disease.","volume":"55","author":"LS Forno","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies.","volume":"388","author":"MG Spillantini","year":"1997","journal-title":"Nature"},{"key":"ref25","first-page":"1169","article-title":"Abnormal distribution of the non-Abeta component of Alzheimer&apos;s disease amyloid precursor\/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment.","volume":"78","author":"A Takeda","year":"1998","journal-title":"Lab Invest"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s004010050576","article-title":"Neurofibrillary tangles in the dentate granule cells of patients with Alzheimer&apos;s disease, Lewy body disease and progressive supranuclear palsy.","volume":"93","author":"K Wakabayashi","year":"1997","journal-title":"Acta Neuropathol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF01276421","article-title":"Pattern of brain destruction in Parkinson&apos;s and Alzheimer&apos;s diseases.","volume":"103","author":"H Braak","year":"1996","journal-title":"J Neural Transm"},{"key":"ref28","first-page":"459","article-title":"[Neuroanatomy of Parkinson disease. Changes in the neuronal cytoskeleton of a few disease-susceptible types of neurons lead to progressive destruction of circumscribed areas in the limbic and motor systems].","volume":"71","author":"H Braak","year":"2000","journal-title":"Nervenarzt"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.2000.tb06899.x","article-title":"Clinical and neuropathological correlates of dementia with Lewy bodies.","volume":"920","author":"E Gomez-Tortosa","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1523\/JNEUROSCI.17-12-04688.1997","article-title":"Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation.","volume":"17","author":"A Luthi","year":"1997","journal-title":"J Neurosci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0002-9440(10)63072-6","article-title":"Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model.","volume":"159","author":"PJ Kahle","year":"2001","journal-title":"Am J Pathol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/elps.1150180303","article-title":"Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients.","volume":"18","author":"T Rabilloud","year":"1997","journal-title":"Electrophoresis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/1522-2683(200106)22:10<1887::AID-ELPS1887>3.0.CO;2-Q","article-title":"An immunoblotting method for high-resolution isoelectric focusing of protein isoforms on immobilized pH gradients.","volume":"22","author":"H Towbin","year":"2001","journal-title":"Electrophoresis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0024834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,16]],"date-time":"2019-06-16T13:59:12Z","timestamp":1560693552000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0024834"}},"subtitle":[],"editor":[{"given":"Koichi M.","family":"Iijima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,9,26]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,9,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0024834","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,26]]}}}